Literature DB >> 12750535

Trends in stroke incidence and 10-year survival in Söderhamn, Sweden, 1975-2001.

Andreas Terént1.   

Abstract

BACKGROUND AND
PURPOSE: Stroke mortality rates have declined in many countries. Stroke incidence rates have also declined, but not to the same extent and not always in parallel with stroke mortality. The aim of the present study was to investigate trends in stroke incidence and long-term survival in a Swedish population.
METHODS: A population-based survey of the incidence of first-ever stroke was performed prospectively in the periods 1975 to 1977, 1983 to 1986, and 1987 to 1990. Case fatality ratios and survival rates were followed to 2001.
RESULTS: Crude incidence rates increased between 1975 to 1977 and 1983 to 1986, but age- and sex-adjusted incidence rates were stable during the whole period of 1975 to 1990. The incidence of intracerebral hemorrhage decreased by approximately two thirds, whereas the incidence of mild brain infarction almost doubled. The case fatality ratio at 28 days did not change, but the 10-year survival ratio increased from 13% to 35%. Mean survival time increased significantly among patients with intracerebral hemorrhage and brain infarction but not among patients with subarachnoidal hemorrhage or stroke of undetermined origin.
CONCLUSIONS: Stroke incidence and short-term case fatality did not change between 1975 and 1990 in the Söderhamn population. Long-term survival after stroke, on the other hand, has continued to improve to 2001. The implication of these changes is that the burden of stroke is likely to increase unless strokes are becoming less severe.

Entities:  

Mesh:

Year:  2003        PMID: 12750535     DOI: 10.1161/01.STR.0000074038.71700.1C

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Sex-related time-dependent variations in post-stroke survival--evidence of a female stroke survival advantage.

Authors:  Tom Skyhøj Olsen; Christian Dehlendorff; Klaus Kaae Andersen
Journal:  Neuroepidemiology       Date:  2007-12-13       Impact factor: 3.282

2.  Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease--a cost-effectiveness analysis.

Authors:  Torbjørn Wisløff; Randi M Selmer; Sigrun Halvorsen; Atle Fretheim; Ole F Norheim; Ivar Sønbø Kristiansen
Journal:  BMC Cardiovasc Disord       Date:  2012-04-04       Impact factor: 2.298

3.  The use of national administrative data to describe the spatial distribution of in-hospital mortality following stroke in France, 2008-2011.

Authors:  Adrien Roussot; Jonathan Cottenet; Maryse Gadreau; Maurice Giroud; Yannick Béjot; Catherine Quantin
Journal:  Int J Health Geogr       Date:  2016-01-11       Impact factor: 3.918

4.  The Effects of Modified Constraint-Induced Movement Therapy in Acute Subcortical Cerebral Infarction.

Authors:  Changshen Yu; Wanjun Wang; Yue Zhang; Yizhao Wang; Weijia Hou; Shoufeng Liu; Chunlin Gao; Chen Wang; Lidong Mo; Jialing Wu
Journal:  Front Hum Neurosci       Date:  2017-05-18       Impact factor: 3.169

5.  Time trends in stroke incidence and in prevalence of risk factors in Southern Germany, 1989 to 2008/09.

Authors:  Inke Thiele; Jakob Linseisen; Margit Heier; Rolf Holle; Inge Kirchberger; Annette Peters; Barbara Thorand; Christa Meisinger
Journal:  Sci Rep       Date:  2018-08-10       Impact factor: 4.379

6.  Stroke in birjand, iran: a hospital-based study of acute stroke.

Authors:  Mohammad Dehghani Firoozabadi; Toba Kazemi; Gholamreza Sharifzadeh; Somayeh Dadbeh; Parvaneh Dehghan
Journal:  Iran Red Crescent Med J       Date:  2013-03-05       Impact factor: 0.611

7.  5-year survival and rehospitalization due to stroke recurrence among patients with hemorrhagic or ischemic strokes in Singapore.

Authors:  Yan Sun; Sze Haur Lee; Bee Hoon Heng; Vivien S Chin
Journal:  BMC Neurol       Date:  2013-10-03       Impact factor: 2.474

8.  Risk factors and 30-day case fatality of first-ever stroke in Basrah, Iraq.

Authors:  Jasim N Al-Asadi; Husam A Habib
Journal:  Niger Med J       Date:  2014-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.